Search research articles
Contact Us
Filters
Showing results (351-360 of 375) with videos related to
Page
of 38
Sort By:
Gastroenterology
|
August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study
Willem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
European Journal of Gastroenterology & Hepatology
|
December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool
Carla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Alimentary Pharmacology & Therapeutics
|
September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
Rozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.
The American Journal of Gastroenterology
|
January 9, 2023
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis
Rozanne C de Veer, Maria C van Hooff, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)
|
December 9, 2017
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history
Carla F Murillo Perez, Jorn C Goet, Willem J Lammers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 8, 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis
Angela C Cheung, Willem J Lammers, Carla F Murillo Perez, et al.
The New England Journal of Medicine
|
November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Kris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
European Journal of Gastroenterology & Hepatology
|
December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe
Carla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.
The American Journal of Gastroenterology
|
July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase
Carla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 375) with videos related to
Sort By:
Page
of 38
Gastroenterology
|
August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study
Willem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
European Journal of Gastroenterology & Hepatology
|
December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool
Carla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Alimentary Pharmacology & Therapeutics
|
September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
Rozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.
The American Journal of Gastroenterology
|
January 9, 2023
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis
Rozanne C de Veer, Maria C van Hooff, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)
|
December 9, 2017
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history
Carla F Murillo Perez, Jorn C Goet, Willem J Lammers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 8, 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis
Angela C Cheung, Willem J Lammers, Carla F Murillo Perez, et al.
The New England Journal of Medicine
|
November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Kris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
European Journal of Gastroenterology & Hepatology
|
December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe
Carla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.
The American Journal of Gastroenterology
|
July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase
Carla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Page
of 38